LEISHMANIASIS
Leishmaniasis is a disease caused by protozoan parasites that belong to the genus Leishmania and is transmitted by the bite of
certain species ofsand fly . Elsewhere
in the world, the genus Phlebotomus is considered the vector of
leishmaniasis.
Most
forms of the disease are transmissible only from animals (zoonosis), but some can be
spread between humans. Human infection is caused by about 21 of 30 species that
infect mammals, the different species are morphologically indistinguishable,
but they can be differentiated by isoenzyme analysis, DNA sequence
analysis, or monoclonal antibodies.
Cutaneous leishmaniasis is the most common form of
leishmaniasis. Visceral leishmaniasis is a severe form in which the
parasites migrate to the vital organs. Leishmaniasis is a parasitic disease that
is found in parts of the tropics, subtropics, and southern Europe. It is
classified as a Neglected Tropical Disease (NTD).
Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the
bite of phlebotomine sand flies.
The symptoms of leishmaniasis are skin sores which erupt weeks to months
after the person affected is bitten by sand flies. Other consequences, which
can manifest anywhere from a few months to years after infection, include
fever, damage to the spleen and liver,
and anemia.
In clinical medicine, leishmaniasis is considered one of
the classic causes of a markedly enlarged (and therefore palpable) spleen; the
organ, which is not normally felt during examination of the abdomen, may become
larger even than the liver in severe cases.
Leishmaniasis may be divided into the following
types.
·
Cutaneous leishmaniasis is the most common form, which
causes a sore at the bite site, which heals in a few months to a year, leaving
an unpleasant-looking scar. This form can progress to any of the other three
forms.
·
Diffuse cutaneous leishmaniasis produces widespread skin
lesions which resemble leprosy, and is particularly difficult to treat.
·
Mucocutaneous leishmaniasis commences with skin ulcers
which spread, causing tissue damage, to, particularly, the nose and mouth.
Leishmaniasis is
transmitted by the bite of female phlebotomine sandflies. The sandflies inject
the infective stage, metacyclic promastigotes, during blood meals (1). Metacyclic promastigotes that reach the puncture wound are
phagocytized by macrophages (2) and transform into amastigotes (3). Amastigotes multiply in
infected cells and affect different tissues, depending in part on whichLeishmania species is involved (4). These differing tissue
specificities cause the differing clinical manifestations of the various forms
of leishmaniasis. Sandflies become infected during blood meals on infected
hosts when they ingest macrophages infected with amastigotes (5,6). In the sandfly's midgut,
the parasites differentiate into promastigotes (7), which multiply,
differentiate into metacyclic promastigotes, and migrate to the proboscis (8).
Leishmaniasis
is caused by infection with the pathogen Leishmania.
The genomes of three Leishmaniaspecies (L. major, L. infantum, and L. braziliensis) have been
sequenced and this has provided much information about the biology of the parasite. For example, in Leishmania, protein-coding
genes are understood to be organized as large polycistronic units in a
head-to-head or tail-to-tail manner; RNA polymerase II transcribes long
polycistronic messages in the absence of defined RNA pol II promoters, and Leishmania has unique features with respect to
the regulation of gene expression in response to changes in the environment.
The new knowledge from these studies may help identify new targets for urgently
needed drugs and aid the development of vaccines.[1]
Currently, no vaccines are in routine use. However, the genomic sequence of Leishmania has
provided a rich source of vaccine candidates. Genome-based approaches have been used to screen for novel vaccine
candidates. One study screened 100 randomly selected genes as DNA vaccines
againstL. major infection in mice. Fourteen
reproducibly protective, novel vaccine candidates were identified. A separate
study used a two-step procedure to identify T cell antigens. Six unique clones
were identified: glutamine synthetase, a transitional endoplasmic reticulum
ATPase, elongation factor 1gamma, kinesin K-39, repetitive protein A2, and a
hypothetical conserved protein. The 20 antigens identified in these two studies
are being further evaluated for vaccine development.[4]
അഭിപ്രായങ്ങളൊന്നുമില്ല:
ഒരു അഭിപ്രായം പോസ്റ്റ് ചെയ്യൂ
നിങ്ങളുടെ അഭിപ്രായങ്ങള് ഇവിടെ അറിയിക്കുക